Emerson Exchange 365
Search
Sign-In / Register
Site
Search
Sign-In/Register
Services
Products
Control & Safety Systems
Asset Management
Measurement Instrumentation
Valves, Actuators & Regulators
Fluid Control & Pneumatics
Electrical Components & Lighting
Welding, Assembly & Cleaning
IIoT & Digital Transformation
Industries
Chemical
Food and Beverage
Industrial Energy
Life Sciences
Oil & Gas
Power
Refining
Other Industries
Women in STEM
Events
Düsseldorf 2024
Immerse - Anaheim 2023
Grapevine 2022
Nashville 2019
San Antonio 2018
The Hague 2018
World
China
South Korea
Russia
More
Cancel
Products
More
Control & Safety Systems
Operations Management Blog
Forums
Blogs
Library/Resources
Members
Tags
More
Cancel
Create New Post
Comment or Question? Become a member of this Emerson Exchange 365 group. Click here to join.
By name
By post count
By last updated date
Descending
Ascending
DeltaV Blog
DeltaV distributed control system blog
779
posts
Real-World Implications of Spectral PAT for Life Sciences
over 1 year ago
Operations Management Blog
193
posts
Digital transformation in chemical processing: how to start small to scale big..
2 months ago
Ovation Blog
112
posts
Mapping the Future of Industrial Software
over 1 year ago
PAC Systems & Industrial Computing Blog
66
posts
Emerson’s PACK EXPO Preview: Trends, Tech, and More!
8 months ago
Safety Instrumented Systems Blog
171
posts
Meeting Safety Challenges in Hydrogen Applications
12 days ago
>
Activity
Tags
Subscribe by email
More
Cancel
By date
By view count
By comment count
Descending
Ascending
Improving Batch Manufacturing Quality Review Cycle Time
Jim Cahill
Exceptions in batch manufacturing processes are the deviations that occur outside the prescribed specifications. For pharmaceutical and biopharmaceutical manufacturers, quality and manufacturing personnel must review these exceptions. Traditionally, this quality review process occurs after the batch has completed. A recent news release, Emerson Helps Life Sciences Companies Reduce Time to Market with Faster Quality…
29 May 2018
Improving Batch Manufacturing Quality Review Cycle Time
Jim Cahill
Exceptions in batch manufacturing processes are the deviations that occur outside the prescribed specifications. For pharmaceutical and biopharmaceutical manufacturers, quality and manufacturing personnel must review these exceptions. Traditionally, this quality review process occurs after the batch has completed. A recent news release, Emerson Helps Life Sciences Companies Reduce Time to Market with Faster Quality…
29 May 2018
Improving Batch Manufacturing Quality Review Cycle Time
Jim Cahill
Exceptions in batch manufacturing processes are the deviations that occur outside the prescribed specifications. For pharmaceutical and biopharmaceutical manufacturers, quality and manufacturing personnel must review these exceptions. Traditionally, this quality review process occurs after the batch has completed. A recent news release, Emerson Helps Life Sciences Companies Reduce Time to Market with Faster Quality…
29 May 2018
Improving Batch Manufacturing Quality Review Cycle Time
Jim Cahill
Exceptions in batch manufacturing processes are the deviations that occur outside the prescribed specifications. For pharmaceutical and biopharmaceutical manufacturers, quality and manufacturing personnel must review these exceptions. Traditionally, this quality review process occurs after the batch has completed. A recent news release, Emerson Helps Life Sciences Companies Reduce Time to Market with Faster Quality…
29 May 2018
Identify and Resolve Cell Therapy Batch Manufacturing Exceptions
Jim Cahill
We conclude our series on improving cell therapy manufacturing with a closer look at the review by exception process. In the manufacturing process of cell therapeutics, product cycle times are extremely short and any exceptions occurring during the production process must be found and addressed quickly. Emerson’s Bob Schiros notes that manufacturing execution systems, such as the Syncade MES , must include this…
20 Feb 2018
Identify and Resolve Cell Therapy Batch Manufacturing Exceptions
Jim Cahill
We conclude our series on improving cell therapy manufacturing with a closer look at the review by exception process. In the manufacturing process of cell therapeutics, product cycle times are extremely short and any exceptions occurring during the production process must be found and addressed quickly. Emerson’s Bob Schiros notes that manufacturing execution systems, such as the Syncade MES , must include this…
20 Feb 2018
Identify and Resolve Cell Therapy Batch Manufacturing Exceptions
Jim Cahill
We conclude our series on improving cell therapy manufacturing with a closer look at the review by exception process. In the manufacturing process of cell therapeutics, product cycle times are extremely short and any exceptions occurring during the production process must be found and addressed quickly. Emerson’s Bob Schiros notes that manufacturing execution systems, such as the Syncade MES , must include this…
20 Feb 2018
Identify and Resolve Cell Therapy Batch Manufacturing Exceptions
Jim Cahill
We conclude our series on improving cell therapy manufacturing with a closer look at the review by exception process. In the manufacturing process of cell therapeutics, product cycle times are extremely short and any exceptions occurring during the production process must be found and addressed quickly. Emerson’s Bob Schiros notes that manufacturing execution systems, such as the Syncade MES , must include this…
20 Feb 2018
Identify and Resolve Cell Therapy Batch Manufacturing Exceptions
Jim Cahill
We conclude our series on improving cell therapy manufacturing with a closer look at the review by exception process. In the manufacturing process of cell therapeutics, product cycle times are extremely short and any exceptions occurring during the production process must be found and addressed quickly. Emerson’s Bob Schiros notes that manufacturing execution systems, such as the Syncade MES , must include this…
20 Feb 2018
Designing and Building Pharmaceutical and Biotech Smart Factories
Jim Cahill
Pharmaceutical and biotech manufacturers seek to improve both project and operational performance through implementation of smart factory technology. The smart factory fits right into the S95 enterprise automation model and provides out-of-box manufacturing functionality representing the best practice in the industry and complying with the regulation such as cGMP. The smart factory technology connects the plant digitally…
7 Feb 2018
Designing and Building Pharmaceutical and Biotech Smart Factories
Jim Cahill
Pharmaceutical and biotech manufacturers seek to improve both project and operational performance through implementation of smart factory technology. The smart factory fits right into the S95 enterprise automation model and provides out-of-box manufacturing functionality representing the best practice in the industry and complying with the regulation such as cGMP. The smart factory technology connects the plant digitally…
7 Feb 2018
Designing and Building Pharmaceutical and Biotech Smart Factories
Jim Cahill
Pharmaceutical and biotech manufacturers seek to improve both project and operational performance through implementation of smart factory technology. The smart factory fits right into the S95 enterprise automation model and provides out-of-box manufacturing functionality representing the best practice in the industry and complying with the regulation such as cGMP. The smart factory technology connects the plant digitally…
7 Feb 2018
Designing and Building Pharmaceutical and Biotech Smart Factories
Jim Cahill
Pharmaceutical and biotech manufacturers seek to improve both project and operational performance through implementation of smart factory technology. The smart factory fits right into the S95 enterprise automation model and provides out-of-box manufacturing functionality representing the best practice in the industry and complying with the regulation such as cGMP. The smart factory technology connects the plant digitally…
7 Feb 2018
Designing and Building Pharmaceutical and Biotech Smart Factories
Jim Cahill
Pharmaceutical and biotech manufacturers seek to improve both project and operational performance through implementation of smart factory technology. The smart factory fits right into the S95 enterprise automation model and provides out-of-box manufacturing functionality representing the best practice in the industry and complying with the regulation such as cGMP. The smart factory technology connects the plant digitally…
7 Feb 2018
Digital Transformation to Paperless Production
Jim Cahill
Manufacturing processes have long been paper-based with log entries, initialing, signoffs and other transactions to manually record. While automation systems have captured some of this manual recordkeeping, they have not been able to capture everything. In batch manufacturing processes that produce thousands of batches each year, maintaining paper records for each batch is a time-consuming, error-prone, and costly…
2 Feb 2018
Digital Transformation to Paperless Production
Jim Cahill
Manufacturing processes have long been paper-based with log entries, initialing, signoffs and other transactions to manually record. While automation systems have captured some of this manual recordkeeping, they have not been able to capture everything. In batch manufacturing processes that produce thousands of batches each year, maintaining paper records for each batch is a time-consuming, error-prone, and costly…
2 Feb 2018
Digital Transformation to Paperless Production
Jim Cahill
Manufacturing processes have long been paper-based with log entries, initialing, signoffs and other transactions to manually record. While automation systems have captured some of this manual recordkeeping, they have not been able to capture everything. In batch manufacturing processes that produce thousands of batches each year, maintaining paper records for each batch is a time-consuming, error-prone, and costly…
2 Feb 2018
Digital Transformation to Paperless Production
Jim Cahill
Manufacturing processes have long been paper-based with log entries, initialing, signoffs and other transactions to manually record. While automation systems have captured some of this manual recordkeeping, they have not been able to capture everything. In batch manufacturing processes that produce thousands of batches each year, maintaining paper records for each batch is a time-consuming, error-prone, and costly…
2 Feb 2018
Digital Transformation to Paperless Production
Jim Cahill
Manufacturing processes have long been paper-based with log entries, initialing, signoffs and other transactions to manually record. While automation systems have captured some of this manual recordkeeping, they have not been able to capture everything. In batch manufacturing processes that produce thousands of batches each year, maintaining paper records for each batch is a time-consuming, error-prone, and costly…
2 Feb 2018
Reducing Execution Errors in Cell Therapeutics Manufacturing
Jim Cahill
In an earlier post, Managing the Chain of Identity in Cell Therapeutics Manufacturing , we highlighted how the manufacturing process of these cell therapies must be performed with absolute accuracy the first time since each batch is produced for a specific patient. It’s critical during the production process that any execution errors be identified and corrected before completion. Any errors in development, manufacturing…
18 Jan 2018
Reducing Execution Errors in Cell Therapeutics Manufacturing
Jim Cahill
In an earlier post, Managing the Chain of Identity in Cell Therapeutics Manufacturing , we highlighted how the manufacturing process of these cell therapies must be performed with absolute accuracy the first time since each batch is produced for a specific patient. It’s critical during the production process that any execution errors be identified and corrected before completion. Any errors in development, manufacturing…
18 Jan 2018
Reducing Execution Errors in Cell Therapeutics Manufacturing
Jim Cahill
In an earlier post, Managing the Chain of Identity in Cell Therapeutics Manufacturing , we highlighted how the manufacturing process of these cell therapies must be performed with absolute accuracy the first time since each batch is produced for a specific patient. It’s critical during the production process that any execution errors be identified and corrected before completion. Any errors in development, manufacturing…
18 Jan 2018
Reducing Execution Errors in Cell Therapeutics Manufacturing
Jim Cahill
In an earlier post, Managing the Chain of Identity in Cell Therapeutics Manufacturing , we highlighted how the manufacturing process of these cell therapies must be performed with absolute accuracy the first time since each batch is produced for a specific patient. It’s critical during the production process that any execution errors be identified and corrected before completion. Any errors in development, manufacturing…
18 Jan 2018
Reducing Execution Errors in Cell Therapeutics Manufacturing
Jim Cahill
In an earlier post, Managing the Chain of Identity in Cell Therapeutics Manufacturing , we highlighted how the manufacturing process of these cell therapies must be performed with absolute accuracy the first time since each batch is produced for a specific patient. It’s critical during the production process that any execution errors be identified and corrected before completion. Any errors in development, manufacturing…
18 Jan 2018
Managing the Chain of Identity in Cell Therapeutics Manufacturing
Jim Cahill
Medicines produced by pharmaceutical and biotech manufacturers are manufactured in many ways. One particular type of treatment, cell therapy, is defined as : …the transplantation of human or animal cells to replace or repair damaged tissue. From a manufacturing perspective, each therapeutic batch must be perfect the first time — because each batch is produced for a specific patient. The next unique batch, for…
4 Jan 2018
<
>